Cited by 21Pharmacogenetics and Drug MetabolismAntibiotics Pharmacokinetics and EfficacyDrug-Induced Adverse Reactions

The DOI matches its Crossref record.

Pharmacokinetics, Metabolism, and Renal Excretion of Sulfadimidine and Its N4-Acetyl and Hydroxy Metabolites in Humans

Vree, T. B., Hekster, Y. A., Nouws, J. F. M., Baakman, M.·1986·Therapeutic Drug Monitoring

Abstract

Sulfadimidine is acetylated and hydroxylated in humans. The hydroxylation pathways account for 10-20% of the dose, leaving the acetylation as the major metabolic pathway. The hydroxylation pathways are independent of the acetylator phenotype. The plasma concentration-time curve of sulfadimidine in fast acetylators is biphasic, with half-lives of 1.7 and 5.4 h, whereas that in slow acetylators is monophasic, with a half-life of 7.6 h. Hydroxylation of a methyl group in sulfadimidine lowers the protein binding from 90 to 60%, while acetylation does not affect the protein binding. Methyl hydroxylation markedly increases the renal clearance.

Overview

Integrity signals

Registry

Crossref · 10.1097/00007691-198612000-00010

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

Sorted by citations

See all 21

Metadata

Authors
Vree, T. B., Hekster, Y. A., Nouws, J. F. M., & Baakman, M.
Affiliations
Radboud University Nijmegen (NL)
Corresponding author
  • Vree, T. B.
  • Hekster, Y. A.
Venue
Therapeutic Drug Monitoring
Published
1986-12
Volume
8
Issue
4
Pages
434-439
ISSN
0163-4356 (ISSN-L)
OpenAlex
W2003333461
Cited by
21
References
0
Citations by year
2025: 1 · 2024: 2 · 2020: 1 · 2015: 2 · 2012: 1
FWCI
2.25
Type
journal article
Language
en
Open access
closed
Locations
  • Therapeutic Drug Monitoring (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords
sulfamethazine, pharmacokinetics, drug metabolism, hydroxylation, acetylator phenotype, renal excretion, renal clearance, plasma protein binding, half-life, sulfonamide metabolites
MeSH terms
Acetylation, Adult, Female, Half-Life, Humans, Kinetics, Male, Phenotype, Protein Binding, Sulfamethazine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics, Metabolism, and Renal Excretion of Sulfadimidine and Its N4-Acetyl and Hydroxy Metabolites in Humans. https://app.cochat.ai/papers/10.1097/00007691-198612000-00010
The paper
Vree, T. B., Hekster, Y. A., Nouws, J. F. M., & Baakman, M. (1986). Pharmacokinetics, Metabolism, and Renal Excretion of Sulfadimidine and Its N4-Acetyl and Hydroxy Metabolites in Humans. Therapeutic Drug Monitoring. https://doi.org/10.1097/00007691-198612000-00010